What is the best treatment for tinea (ringworm of the scalp) capitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Tinea Capitis

Organism-Directed First-Line Therapy

The best treatment for tinea capitis depends on the causative organism: terbinafine is superior for Trichophyton species infections (2-4 weeks), while griseofulvin is more effective for Microsporum species infections (6-8 weeks). 1, 2

For Trichophyton Species (T. tonsurans, T. violaceum, T. soudanense)

Terbinafine is the preferred first-line agent due to its fungicidal activity and superior efficacy against Trichophyton species 1, 2:

  • Weight-based dosing 1, 2:

    • <20 kg: 62.5 mg daily for 2-4 weeks
    • 20-40 kg: 125 mg daily for 2-4 weeks
    • 40 kg: 250 mg daily for 2-4 weeks

  • Advantages: Shorter treatment duration (2-4 weeks vs 6-8 weeks for griseofulvin) improves compliance 1

  • Side effects: Gastrointestinal disturbances and rashes in <8% of children, with only 0.8% requiring discontinuation 1

For Microsporum Species (M. canis, M. audouinii)

Griseofulvin is the preferred first-line agent and remains the only licensed treatment for tinea capitis in children in the UK 1, 2:

  • Weight-based dosing 1, 2, 3:

    • <50 kg: 15-20 mg/kg/day for 6-8 weeks (single or divided dose)
    • 50 kg: 1 g/day for 6-8 weeks (single or divided dose)

  • Critical caveat: Terbinafine fails against Microsporum because it cannot be incorporated into hair shafts in prepubertal children and doesn't reach the scalp surface where arthroconidia are located 1

  • Important note: 8 weeks of griseofulvin is significantly more effective than 4 weeks of terbinafine for confirmed Microsporum infection 1

When to Start Treatment Empirically

Begin treatment before mycology results if any cardinal clinical signs are present: scale, lymphadenopathy, alopecia, or kerion 1, 2:

  • Collect specimens via scalp scrapings, hair pluck, brush, or swab for microscopy and culture 1, 2
  • Potassium hydroxide microscopy provides rapid preliminary diagnosis 2
  • Topical therapy alone is inadequate—oral therapy is required for both clinical and mycological cure 1, 2

Second-Line Options for Treatment Failure

If initial therapy fails, consider these factors first: poor compliance, suboptimal drug absorption, organism insensitivity, or reinfection 1, 2:

  • If clinical improvement but positive mycology persists: Continue current therapy for an additional 2-4 weeks 1, 2
  • If no clinical improvement: Switch to second-line therapy 1, 2

Second-Line Agents

Itraconazole is effective against both Trichophyton and Microsporum species 1, 2:

  • Dosing: 5 mg/kg/day for 2-4 weeks or 50-100 mg/day for 4 weeks 2

Fluconazole is an alternative for refractory cases 2:

  • Favorable tolerability profile and available in liquid form 2
  • Particularly useful in younger children who cannot swallow tablets 4

Adjunctive Measures

Sporicidal shampoos reduce transmission and hasten spore eradication 2, 4:

  • 2% ketoconazole or 1% selenium sulfide shampoo as adjunctive therapy 2, 4, 5
  • Screen and treat family members and close contacts, especially for T. tonsurans infections 2

Treatment Endpoint and Monitoring

Mycological cure, not just clinical improvement, is the treatment endpoint 2:

  • Repeat mycology sampling until clearance is documented 2
  • Clinical relapse occurs if medication is discontinued before the organism is completely eradicated 3

Common Pitfalls to Avoid

  • Do not use terbinafine for Microsporum infections—it has poor efficacy due to inadequate hair shaft penetration in children 1
  • Do not rely on topical therapy alone—it cannot eradicate scalp infections 1, 2
  • Do not stop treatment based solely on clinical improvement—continue until mycological cure is confirmed 2, 3
  • Avoid underdosing griseofulvin—higher doses (15-20 mg/kg/day) are needed due to increasing treatment failures with lower doses 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Tinea Capitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Therapeutic options in the treatment of tinea capitis.

Expert opinion on pharmacotherapy, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.